Literature DB >> 17688839

Intravenous pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Luis R Espinoza.   

Abstract

Entities:  

Year:  2007        PMID： 17688839     DOI： 10.1007/s11926-007-0048-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  9 in total

1.  Initial intravenous gammaglobulin treatment failure in Kawasaki disease.

Authors:  C A Wallace; J W French; S J Kahn; D D Sherry
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

2.  Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis.

Authors:  K S Barron; D A Person; E J Brewer; M G Beale; A M Robson
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

3.  Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.

Authors:  Angela C Wooditch; Stephen C Aronoff
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

5.  Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.

Authors:  K Hashino; M Ishii; M Iemura; T Akagi; H Kato
Journal:  Pediatr Int       Date:  2001-06       Impact factor: 1.524

6.  Corticosteroid treatment of refractory Kawasaki disease.

Authors:  Bianca A Lang; Rae S M Yeung; Kiem G Oen; Peter N Malleson; Adam M Huber; Mark Riley; Regan Ebbeson; Suzanne E Ramsey; Ronald M Laxer; Earl D Silverman; Brian W McCrindle; Savithiri Ratnapalan; Brian M Feldman
Journal:  J Rheumatol       Date:  2006-04       Impact factor: 4.666

7.  Kawasaki disease: effect of treatment on coronary artery involvement.

Authors:  H Kato; S Koike; T Yokoyama
Journal:  Pediatrics       Date:  1979-02       Impact factor: 7.124

8.  Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group.

Authors:  J C Burns; E V Capparelli; J A Brown; J W Newburger; M P Glode
Journal:  Pediatr Infect Dis J       Date:  1998-12       Impact factor: 2.129

9.  Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.

Authors:  D A Wright; J W Newburger; A Baker; R P Sundel
Journal:  J Pediatr       Date:  1996-01       Impact factor: 4.406
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.